The Canadian Agency for Drugs and Technologies in Health (CADTH) has published a report summarising the current clinical evidence and findings of guidelines and recommendations on the management of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents, and exploring the current utilisation patterns and costs associated with the use of long- and short-acting ADHD medications within Canada.   Please see the link below for details.